Key Feature
- The use of reverse genetics technology to obtain recombinant rabies virus (r3G strain) carrying the 3G gene as the production strain, which has 2 to 2.5 times more immunogenic genes than the traditional vaccine strain, increasing immunogenicity by 2 to 2.5 times.
- The virus proliferation efficiency is increased by 10 times by using the suspension culture process.
- The use of inactivated β-propiolactone, which is less toxic and has no residual effects, effectively reduces the irritation of the vaccine to the vaccination site and reduces the rate of side reactions.
【Main constituents and content】Contains inactivated rabies virus strain r3G with a pre-inactivation viral content of 108.2FFU/ml
【Character】Pinkish suspension for injection. Prolonged storage can lead to the formation of a shake-out precipitate.
【Indications and usage】Provide protection against rabies in dogs. The duration of immunity is 12 months.
【Administration and dosage】Intramuscular injection for dog at its ting. For dogs at 3 months of age or older, 1ml per dog (including 1 head portion). Determine rabies virus antibodies at 30-60 days post immunity. If the antibody level is less than 0.5 IU/ml, revaccination should be given promptly, and every 12 months thereafter.
【Precautions】
- This product is only for healthy dogs.
- Shake well and allow the vaccine to return to room temperature (15 to 25°C) before use.
- Use entire contents when first opened
- If the vaccine vial is discoloration, emulsification, bottle breakage, mixed foreign matter, etc., Do Not Use.
- If vaccination of pregnant dogs is required protective measures should be taken to avoid mechanical abortion.
- Any unused vaccine vial, utensils and vaccines remaining after dilution derived from such veterinary medicinal product should be disposed of by harmless treatment.
【Storage and shelf life】Store between 2℃ and 8℃, valid for 24 months.
